ScienceDaily: Latest Science News |
- UC Davis researchers discover molecular target for the bacterial infection brucellosis
- Type 1 diabetes study identifies subset of patients with strong response to therapy
- Chemists devise new way to prepare molecules for drug testing
| UC Davis researchers discover molecular target for the bacterial infection brucellosis Posted: 15 Aug 2013 02:24 PM PDT Scientists have uncovered a potential drug target for the development of an effective therapy against the debilitating, chronic form of the bacterial disease brucellosis, which primarily afflicts people in Mediterranean and Middle Eastern countries.  |
| Type 1 diabetes study identifies subset of patients with strong response to therapy Posted: 15 Aug 2013 02:22 PM PDT Primary results from a new clinical trial show that a discrete subset of patients with type 1 diabetes treated with the monoclonal antibody teplizumab (MacroGenics, Inc.) demonstrated especially robust response with greater preservation of C-peptide, a biomarker of islet cell function, compared to controls, suggesting that these patients could be identified prior to treatment.  |
| Chemists devise new way to prepare molecules for drug testing Posted: 15 Aug 2013 01:15 PM PDT James Bond had his reasons for ordering his martinis "shaken, not stirred." Similarly, drug manufacturers need to make sure the molecules in a new drug are arranged in an exact manner, lest there be dire consequences.  |
| You are subscribed to email updates from ScienceDaily: Latest Science News To stop receiving these emails, you may unsubscribe now. | Email delivery powered by Google |
| Google Inc., 20 West Kinzie, Chicago IL USA 60610 | |
No comments:
Post a Comment